InvestorsHub Logo
icon url

DragonBear

06/23/20 11:07 AM

#126628 RE: concordia #126617

Waggoner highlighted the 2016 milestones that PharmaCyte’s shareholders and investment community can look forward to this year:

Then he found out there were these pesky pre-clinical tests that would have to be run. Along with quite a bit more in the GMP area.

My all time favorite is how they were going to test against Gemcitabine+Abraxane. Yep crank up an arm where the patient's cancer was already resistant to the drugs, and compare it to the Kenny Wonder Treatment. That protocol would've gone over well with the FDA. LOL Along with screw the idea PC CTs, even ones with accelerated approval are taking 2+ yrs for Phase 2, and up to 4 yrs for Phase 3. The Kenny Wonder Treatment will be ready for marketing after 6 months.

Then one has Von Hoff and his TD2 taking off. Never to return.

And whatever happened to that diabetes thingy? Promise the moon. Deliver the mold off the cheese.